Histology
Basal Cell Carcinoma
CI-CAN-00000479Explore in graph →
57 active trials4 approved drugs6 evidence items
Loading cancer entity…
Loading cancer entity…
Histology
CI-CAN-00000479Explore in graph →
Clinical trials
361 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (25)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02639117 | Photodynamic Therapy and Vismodegib for Multiple Basal Cell Carcinomas(PDT-Vismo) | completed | Phase 1 | 4 | University of ArizonaOTHER | 1 | Jul 18, 2018 | clinicaltrials |
| NCT03569345 | Basal Cell Carcinomas Treated With Ablative Fractional Laser and Ingenol Mebutate | completed | Phase 1 / Phase 2 | 20 | Merete HaedersdalOTHER | 1 | Jul 10, 2018 | clinicaltrials |
| NCT01791894 |
| Arsenic Trioxide in Treating Patients With Basal Cell Carcinoma(ATO) |
| completed |
| Phase 1 / Phase 2 |
| 5 |
| Stanford UniversityOTHER |
| 1 |
| Jun 8, 2018 |
| clinicaltrials |
| NCT02550678 | A Study of the Efficacy and Safety of ASN-002 in Adult Patients With Low-risk Nodular Basal Cell Carcinoma(ASN-002-001) | completed | Phase 1 / Phase 2 | 16 | Ascend Biopharmaceuticals LtdINDUSTRY | 1 | Jun 6, 2018 | clinicaltrials |
| NCT02007317 | Safety and Efficacy of Oshadi D and Oshadi R in Basal Cell Carcinoma Patients Prior to Tumor Excision a Phase 2 Study | completed | Phase 2 | 30 | Oshadi Drug AdministrationINDUSTRY | 1 | Apr 18, 2018 | clinicaltrials |
| NCT03482622 | Intraoperative Detection of Residual BCC by Fast Raman | unknown | — | 600 | University of NottinghamOTHER | 0 | Mar 29, 2018 | clinicaltrials |
| NCT00601185 | Confocal Reflectance Microscopy of Shave-Biopsy Sites on Skin in Vivo. | completed | — | 116 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 27, 2018 | clinicaltrials |
| NCT02438644 | Observational Study of Vismodegib (Erivedge) in Patients Treated in Argentina | completed | — | 75 | Hoffmann-La RocheINDUSTRY | 0 | Feb 26, 2018 | clinicaltrials |
| NCT03012009 | Laser Assisted Drug Delivery in the Treatment of Superficial Non Melanoma Skin Cancer: a Randomized Controlled Trial | completed | N/A | 16 | University Hospital, GhentOTHER | 1 | Jan 25, 2018 | clinicaltrials |
| NCT01631331 | Vismodegib in Treating Patients With Basal Cell Carcinoma (BCC) | completed | Early Phase 1 | 15 | Stanford UniversityOTHER | 1 | Dec 8, 2017 | clinicaltrials |
| NCT01482104 | New Versus Approved Methyl-aminolevulinate Photodynamic Therapy (MAL-PDT) Regime in Basal Cell Carcinoma (BCC) | completed | N/A | 277 | Norwegian University of Science and TechnologyOTHER | 1 | Oct 27, 2017 | clinicaltrials |
| NCT01815840 | A Study of Two Vismodegib Regimens in Participants With Multiple Basal Cell Carcinomas | completed | Phase 2 | 229 | Hoffmann-La RocheINDUSTRY | 10 | Sep 28, 2017 | clinicaltrials |
| NCT02409628 | EktoTherix™ Regenerative Tissue Scaffold for Repair of Surgical Excision Wounds | completed | N/A | 12 | Neotherix LimitedINDUSTRY | 1 | Sep 15, 2017 | clinicaltrials |
| NCT01604252 | An Observational Study of Treatment Patterns and Effectiveness and Safety Outcomes in Advanced Basal Cell Carcinoma and Basal Cell Carcinoma Nevus Syndrome Patients(RegiSONIC) | terminated | — | 503 | Genentech, Inc.INDUSTRY | 2 | Jul 28, 2017 | clinicaltrials |
| NCT02100111 | An Analysis of Treatment Patterns and Outcomes for Basal Cell Carcinoma (BCC) Cancer Participants | completed | — | 134 | Hoffmann-La RocheINDUSTRY | 4 | Jul 24, 2017 | clinicaltrials |
| NCT02321982 | Same-day Versus Separate-day Preoperative Consultation for Mohs Surgery | withdrawn | N/A | 0 | Dartmouth-Hitchcock Medical CenterOTHER | 0 | Jul 6, 2017 | clinicaltrials |
| NCT01898598 | A Study of Vismodegib With Surgery in Participants With Previously Untreated Basal Cell Carcinoma | terminated | Phase 2 | 18 | Hoffmann-La RocheINDUSTRY | 1 | May 8, 2017 | clinicaltrials |
| NCT03070691 | Efficacy, Safety and Tolerability of Topically Applied LDE225 Cream (Hedgehog Pathway Inhibitor) in Adult Patients With Nevoid Basal Cell Carcinoma Syndrome (NBCCS) | withdrawn | Phase 2 / Phase 3 | 0 | Novartis PharmaceuticalsINDUSTRY | 10 | May 5, 2017 | clinicaltrials |
| NCT01773447 | Set-back Suture Versus Traditional Vertical Mattress Suture | completed | N/A | 47 | University of California, DavisOTHER | 1 | Mar 31, 2017 | clinicaltrials |
| NCT00218829 | DMSO-PDT of BCC - A 6 Year Follow up | completed | — | 44 | Norwegian University of Science and TechnologyOTHER | 0 | Mar 14, 2017 | clinicaltrials |
| NCT01529450 | Pilot LDE225 in Locally Advanced or Metastatic BCC + Previously Tx Non-LDE225 Smoothened Inhibitors | completed | N/A | 11 | Anne ChangOTHER | 1 | Jan 16, 2017 | clinicaltrials |
| NCT02939027 | Study of Electronic Brachytherapy for Cutaneous Basal Cell Carcinoma | completed | N/A | 40 | Instituto de Investigacion Sanitaria La FeOTHER | 0 | Oct 19, 2016 | clinicaltrials |
| NCT02666833 | Optical Imaging for Preoperative Delineation of Nonmelanoma Skin Cancers(PERFIS) | unknown | — | 40 | Massachusetts General HospitalOTHER | 1 | Sep 15, 2016 | clinicaltrials |
| NCT00237107 | Debulking Effect of Curretage on Basal Cell Carcinomas - a Histological Assessment. | completed | N/A | 36 | Norwegian University of Science and TechnologyOTHER | 0 | Jul 19, 2016 | clinicaltrials |
| NCT00003611 | Acitretin in Preventing Skin Cancers in Patients With Previously Treated Skin Cancers Who Have Undergone Organ Transplantation | completed | N/A | 129 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jul 13, 2016 | clinicaltrials |
| NCT01808950 | Efficacy and Safety Trial of Topical Resiquimod Gel (0.06%) in Patients With Nodular Basal Cell Carcinoma | terminated | Phase 1 / Phase 2 | 4 | Spirig Pharma Ltd.INDUSTRY | 2 | Jun 22, 2016 | clinicaltrials |
| NCT02029352 | Topical Green Tea Ointment in Treatment of Superficial Skin Cancer | completed | Phase 2 / Phase 3 | 42 | Maastricht University Medical CenterOTHER | 1 | May 18, 2016 | clinicaltrials |
| NCT02285790 | One-stop-shop Study for Treatment of Basal Cell Carcinoma Using Reflectance Confocal Microscopy(B-OSS) | completed | N/A | 100 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Apr 13, 2016 | clinicaltrials |
| NCT02059252 | Safety, Tolerability and Performance of SmartMatrix Dermal Replacement Scaffold | terminated | Phase 1 / Phase 2 | 5 | Smart Matrix LimitedOTHER | 1 | Apr 4, 2016 | clinicaltrials |
| NCT01325688 | PEP005 Gel - Evaluation of the Safety and Efficacy of Ingenol Mebutate Gel on a Superficial Basal Cell Carcinoma on the Trunk or Extremities | completed | Phase 2 | 75 | PeplinINDUSTRY | 1 | Feb 26, 2016 | clinicaltrials |
| NCT00432185 | To Determine the Maximum Tolerated Dose Level (MTD) of PEP005 Topical Gel in Patients With sBCC | completed | Phase 2 | 117 | PeplinINDUSTRY | 1 | Feb 15, 2016 | clinicaltrials |
| NCT01903239 | Long Term Prospective Study Evaluating Effectiveness of Narrow Margins for Low-Risk Head and Neck Basal Cell Carcinomas | unknown | N/A | 179 | Thomas Jefferson UniversityOTHER | 1 | Feb 5, 2016 | clinicaltrials |
| NCT00574392 | Multi-Wavelength and Coherence Confocal Reflectance Microscopy of Pigmented and Non-Pigmented Lesions on the Skin In-Vivo | completed | — | 50 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 18, 2015 | clinicaltrials |
| NCT00089180 | T4N5 Liposomal Lotion in Preventing The Recurrence of Nonmelanoma Skin Cancer in Patients Who Have Undergone a Kidney Transplant | completed | Phase 2 | 100 | National Cancer Institute (NCI)NIH | 1 | Dec 4, 2015 | clinicaltrials |
| NCT01033019 | To Evaluate the Safety, Local Tolerability, PK and PD of LDE225 on Sporadic Superficial and Nodular Skin Basal Cell Carcinomas (sBCC) | terminated | Phase 2 | 25 | Novartis PharmaceuticalsINDUSTRY | 2 | Oct 30, 2015 | clinicaltrials |
| NCT01350115 | Efficacy, Safety and Pharmacokinetics of Oral LDE225 in Treatment of Patients With Nevoid Basal Cell Carcinoma Syndrome (NBCCS) | completed | Phase 2 | 10 | Novartis PharmaceuticalsINDUSTRY | 4 | Oct 19, 2015 | clinicaltrials |
| NCT02576769 | The Role of Melanocyte in Basal Cell Carcinoma | unknown | — | 30 | Universidad Autonoma de San Luis PotosíOTHER | 1 | Oct 15, 2015 | clinicaltrials |
| NCT00397384 | Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer | completed | Phase 1 | 43 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2015 | clinicaltrials |
| NCT02158650 | Video-Based Treatment Options for Basal Cell Carcinoma | completed | N/A | 32 | Emory UniversityOTHER | 1 | Aug 17, 2015 | clinicaltrials |
| NCT01160250 | A Study of Vismodegib (GDC-0449) in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma | approved for marketing | — | — | Genentech, Inc.INDUSTRY | 1 | Aug 6, 2015 | clinicaltrials |
| NCT01260987 | Fractional CO2 Laser Assisted Photodynamic Therapy | completed | Phase 2 / Phase 3 | 47 | Bispebjerg HospitalOTHER | 1 | Jul 30, 2015 | clinicaltrials |
| NCT02507076 | Isolated Limb Perfusion With Melphalan in Treating Patients With Stage IIIB-IV Melanoma or Sarcoma | withdrawn | N/A | 0 | Albert Einstein College of MedicineOTHER | 1 | Jul 23, 2015 | clinicaltrials |
| NCT01770002 | Eversion in Dermatologic Surgery: Is Cosmetic Appearance Improved? | completed | N/A | 50 | University of California, DavisOTHER | 1 | Apr 16, 2015 | clinicaltrials |
| NCT00994240 | Cure Rates of Superficial Basal Cell Carcinoma (BCC) EDC | terminated | N/A | 85 | University of Wisconsin, MadisonOTHER | 1 | Feb 27, 2015 | clinicaltrials |
| NCT00108121 | Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Nodular Basal Cell Carcinoma | completed | Phase 2 | 60 | PeplinINDUSTRY | 1 | Jan 19, 2015 | clinicaltrials |
| NCT01358045 | Topical Vitamin D3, Diclofenac or a Combination of Both to Treat Basal Cell Carcinoma | completed | Phase 2 | 128 | Maastricht University Medical CenterOTHER | 1 | Jan 13, 2015 | clinicaltrials |
| NCT01292668 | Photodynamic Therapy Using Methyl-5-Aminolevulinate Hydrochloride Cream in Determining Pain Threshold in Patients With Skin Cancer | completed | Phase 1 | 21 | Roswell Park Cancer InstituteOTHER | 1 | Sep 29, 2014 | clinicaltrials |
| NCT01543581 | Vismodegib for Treatment of Basal Cell Carcinoma(Erivedge) | completed | Phase 2 | 3 | Abel Torres, MDOTHER | 0 | Sep 26, 2014 | clinicaltrials |
| NCT00670189 | A Phase 1 Study of BMS-833923 (XL139) in Subjects With Advanced or Metastatic Cancer | completed | Phase 1 | 53 | Bristol-Myers SquibbINDUSTRY | 2 | Aug 15, 2014 | clinicaltrials |
| NCT00374062 | Effect of the Subconscious on Mohs Micrographic Surgery | completed | N/A | 150 | Northwestern UniversityOTHER | 1 | Jul 15, 2014 | clinicaltrials |
Data updated 23 days agoSource updated Jul 18, 2018source: clinicaltrials